A. Efremushkina

Place of Prasugrel, P2Y12 receptor antagonist, in an early invasive treatment of patients with acute coronary syndrome (according to the results of multicenter randomized controlled trial ISAR-REACT 5)

S. A. Ustyugov, D. Duplyakov, O. Averkov, 2019, Russian Journal of Cardiology.

Change in muscle strength of the hand flexors, muscle-to-fat ratio and walking speed in ­middle-aged patients living in rural areas after myocardial infarction during cardiac rehabilitation

A. Efremushkina, Ефремушкина Анна Александровна, Ya A Kozhedub, 2019, Kazan medical journal.

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.

Khalid Yusoff, Frederick M. Costello, Martin O'Donnell, 2017, Lancet.

[Iron deficiency in Russia heart failure patients. Observational cross-sectional multicenter study].

A. A. Zemlyanukhina, L. Karapetyan, D. Duplyakov, 2022, Kardiologiia.

The influence of cardiac rehabilitation on the muscular strenght of the hand flexors, muscle mass and walking distance in middle-aged men, depending on the onset of coronary heart disease

A. Efremushkina, Ya A Kozhedub, A. Suvorova, 2019 .

Female and Male Phenotypes of Iron Deficiency in CHF. Additional analysis of the «The Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (J-CHF-RF)» study.

A. A. Zemlyanukhina, D. Duplyakov, S. Yakushin, 2023, Kardiologiia.